These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 4940644)
1. [Susceptibility of mice from various lines to vaccine strains of mycobacterium tuberculosis (BCG)]. Leshchinskaia EN; Nesterenko LA Probl Tuberk; 1971; 49(6):85-7. PubMed ID: 4940644 [No Abstract] [Full Text] [Related]
2. [Experimental study of the biological activity of BCG substrains]. Rozenberg AM Probl Tuberk; 1971; 49(6):80-5. PubMed ID: 4940643 [No Abstract] [Full Text] [Related]
3. Comparative studies of 5 BCG substranins. I. Residual virulence of the French, Soviet, Swedish, Japanese and Rumanian substrains. Gheorghiu M; Paraschiveso M; Petrovici-Venson E Arch Roum Pathol Exp Microbiol; 1969; 28(2):531-9. PubMed ID: 4923821 [No Abstract] [Full Text] [Related]
4. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Ritz N; Tebruegge M; Connell TG; Sievers A; Robins-Browne R; Curtis N Antimicrob Agents Chemother; 2009 Jan; 53(1):316-8. PubMed ID: 18955515 [TBL] [Abstract][Full Text] [Related]
5. [Residual virulence of lyophilized commercial BCG-Brazil vaccine, and of the one cultured in Dubos media for mice]. Fonseca Lde S; Gontijo Filho PP An Microbiol (Rio J); 1979; 24():182-9. PubMed ID: 400665 [No Abstract] [Full Text] [Related]
6. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain. Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955 [TBL] [Abstract][Full Text] [Related]
7. BCG-induced anaemia in mice relates to number of viable units injected intravenously. Marchal G; Milon G; Gheorghiu M; Lebastard M Dev Biol Stand; 1986; 58 ( Pt A)():181-7. PubMed ID: 3297862 [No Abstract] [Full Text] [Related]
8. Haemolytic activity of Mycobacterium spp. Brzychcy M; Andrzejczyk Z; Zalewska N; Zwolska Z; Rudnicka W Acta Microbiol Pol; 1997; 46(4):377-85. PubMed ID: 9516984 [TBL] [Abstract][Full Text] [Related]
9. [Application of multiplex polymerase chain reaction in rapid identification of Mycobacterium bovis BCG]. Li GL; Chen BW; Zhuang YH; Wang GZ; Zhao M; Shen XB; Sun GZ Zhonghua Jie He He Hu Xi Za Zhi; 2003 Nov; 26(11):701-3. PubMed ID: 14703448 [TBL] [Abstract][Full Text] [Related]
10. Development of a Mycobacterium bovis intranasal challenge model in mice. Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980 [TBL] [Abstract][Full Text] [Related]
11. The virulence of some strains of BCG for golden hamsters. Bunch-Christensen K; Ladefoged A; Guld J Bull World Health Organ; 1968; 39(5):821-8. PubMed ID: 4893582 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"]. Buraczewska M; Chodkowska S; Paklerska-Pobratyn H Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544 [No Abstract] [Full Text] [Related]
13. [Diagnostic methods of postvaccinal complications after administration of BCG vaccine]. Zwolska Z; Augustynowicz-Kopeć E; Zabost A; Ziołkowski J; Buchwald J; Płończak M; Walas W; Ziebiński M Przegl Epidemiol; 2004; 58 Suppl 1():123-8. PubMed ID: 15807170 [No Abstract] [Full Text] [Related]
14. Comparative studies with Danish and Prague BCG strains inoculated into the cornea of the rabbits in repeated experiments. Struplová V; Obrucnik M J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):490-1. PubMed ID: 1107420 [No Abstract] [Full Text] [Related]
15. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091 [TBL] [Abstract][Full Text] [Related]
16. The effect of passaging in liquid media and storage on Mycobacterium bovis--BCG growth capacity and infectivity. Nascimento IP; Leite LC FEMS Microbiol Lett; 2005 Feb; 243(1):81-6. PubMed ID: 15668004 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis. Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804 [TBL] [Abstract][Full Text] [Related]
18. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857 [TBL] [Abstract][Full Text] [Related]
19. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate. Heinzmann J; Wilkens M; Dohmann K; Gerlach GF Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053 [TBL] [Abstract][Full Text] [Related]
20. Selection of a BCG population with increased freeze-drying resistance. Stavri D; Stavri H; Drăghici D Dev Biol Stand; 1986; 58 ( Pt A)():139-44. PubMed ID: 3297860 [No Abstract] [Full Text] [Related] [Next] [New Search]